Kimberly Stone, MD is a board certified General Surgeon who specializes in breast surgical oncology and melanoma surgery. She treats all conditions related to breast health including: breast cancer, high risk prevention and screening, benign breast disease, and conditions related to lactation.
Dr. Stone completed a breast surgical oncology fellowship at UCSF, where she trained in all aspects of breast surgical oncology, and melanoma surgery. Dr Stone performs all types of breast surgery including total skin and nipple sparing mastectomy, wireless lumpectomy, benign breast disease excisions and axillary surgery. She works closely with plastic and reconstructive surgeons to offer women the best possible cosmetic options and results following treatment. Dr Stone performs melanoma surgery including wide local excision, sentinel lymph node biopsy, and lymph node dissections for melanoma.
Dr. Stone strives to deliver compassionate, patient-centered surgical care that is expert and evidence-based while at the same time customized to the unique needs of each patient. She believes that patient empowerment and education are at the heart of an excellent care team.
- Fellowship: Univ of California San Francisco (2018) CA
- Fellowship, University of California, San Francisco, Breast Surgical Oncology (2018)
- Board Certification, American Board of Surgery, General Surgery (2017)
- Residency, Stanford Hospital and Clinics, General Surgery (2016)
- Medical Education (MD), University of California, Irvine, Medicine (2009)
- Medical Director, South Bay Operating Room (2018 - Present)
A Review of Anatomy, Physiology, and Benign Pathology of the Nipple
Stone, K., & Wheeler, A. (2015). A Review of Anatomy, Physiology, and Benign Pathology of the Nipple. ANNALS OF SURGICAL ONCOLOGY, 22(10), 3236–40.
The Biology Behind the American College of Surgeons Oncology Group Z0011 Trial
Stone, K., & Wheeler, A. J. (2015). The Biology Behind the American College of Surgeons Oncology Group Z0011 Trial. JAMA SURGERY, 150(12), 1148–49.
A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS)
Wapnir, I., DeMartini, W., Allison, K., Stone, K., Dirbas, F., Marquez, C., … Horst, K. (2020). A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS). CANCER RESEARCH, 80(4).
Stanford Cancer Center South Bay San Jose, CASan Jose, CA
Stanford Women's Cancer Center Palo Alto, CAPalo Alto, CA
Breast Cancer Program in Palo Alto Palo Alto, CAPalo Alto, CA
Breast Cancer Program in San Jose San Jose, CASan Jose, CA
View More »